GSK-NKD20006

Study Sponsor: GSK

Study Title

An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Fixed-Dose Study Comparing the Efficacy and Safety of GW597599B or Paroxetine to Placebo in Moderately to Severely Depressed Patients with Major Depressive Disorder

Medicine or Vaccine (generic name)

vestipitant

Sponsor Identification Number

NKD20006

Trial Registry Identification Number(#'s)

NCT00048204

Medical Condition

Depressive Disorder, Major

Phase

Phase 2

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=NKD20006

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00048204

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An analysis-ready dataset is not available for this study.

Date Added to this Site

May 2015